
Hypera Pharma (HYPE3)
BOV
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Return on Assets (%) | 8.602 | 8.928 | 10.921 | 10.358 | 8.88 | 7.177 | 7.788 | 6.829 |
Return on Equity (%) | 13.949 | 11.662 | 14.115 | 13.713 | 14.43 | 13.948 | 16.562 | 14.864 |
Return on Invested Capital (%) | 13.201 | 12.392 | 14.848 | 12.02 | 12.241 | 11.941 | 17.128 | 15.47 |
Operating Margin (%) | 44.904 | 28.926 | 34.84 | 34.313 | 34.521 | 27.383 | 35.197 | 34.392 |
Net Profit Margin (%) | 25.321 | 24.973 | 30.33 | 35.33 | 31.674 | 22.404 | 22.484 | 20.822 |
Book Value Per Share | 6.398 | 4.643 | 5.386 | 5.971 | 4.487 | -0.258 | -0.694 | 0.136 |
Earnings Per Share | 1.858 | 1.526 | 1.787 | 1.841 | 2.045 | 2.1 | 2.677 | 2.6 |
Cash Per Share | 0.037 | 0.015 | 0.023 | 3.553 | 7.488 | 3.611 | 4.517 | 4.071 |
Working Capital Per Share | 5.711 | 3.506 | 4.585 | 4.985 | 8.321 | 5.865 | 5.215 | 5.416 |
Operating Profit Per Share | 6.079 | 4.436 | 4.462 | 4.456 | 4.747 | 6.302 | 7.813 | 8.308 |
EBIT Per Share | 2.543 | 1.579 | 1.937 | 1.681 | 1.904 | 1.909 | 2.521 | 2.381 |
EBITDA Per Share | 2.543 | 1.579 | 1.937 | 1.681 | 1.904 | 1.909 | 2.521 | 2.381 |
Free Cash Flow Per Share | 2.094 | 1.656 | 1.851 | 2.086 | 2.556 | 2.889 | 4.45 | 4.183 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 632,24M | 632,24M | 632,24M | 632,24M | 633,42M | 633,42M | 633,42M | 633,42M |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Actions en circulation | 633,42M | 633,42M | 633,42M | 633,42M | 633,42M | 633,42M | 633,42M | 633,42M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 12,07B |
Ratio cours/bénéfice | 7,53 |
Ratio prix/ventes | 1,3 |
Ratio prix/liquidités | 4,81 |
Ratio prix/valeur comptable | 1,08 |
Rendement de dividende | - |
Actions en circulation | 633,42M |
Volume moyen (1 semaine) | 18,84M |
Volume moyen (1 mois) | 9,06M |
Variation sur 52 semaines | -42,06% |
Plus haut sur 52 semaines | 34,96 |
Plus bas sur 52 semaines | 16,62 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales